サマリー

呼吸器治療薬の世界市場 2023-2027
呼吸器治療薬市場は2022〜2027年に302.3億米ドル成長し、予測期間中のCAGRは6.38%で加速すると予測されます。この調査レポートは、呼吸器治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、持続可能で安全な呼吸器治療薬へのニーズ、呼吸器疾患の有病率の上昇、タバコ消費の増加によって牽引されています。
Technavioの呼吸器医薬品市場は以下のように区分されます：
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
タイプ別
- 喘息
- 慢性閉塞性肺疾患
- アレルギー性鼻炎
- 嚢胞性線維症
- その他の呼吸器疾患
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、遠隔医療と遠隔モニタリングの出現が、今後数年間の呼吸器治療薬市場の成長を促進する主要な理由の1つであると特定している。また、生物製剤や標的療法の採用、デジタルヘルス統合の高まりは、市場の大きな需要につながる。
呼吸器治療薬市場に関するレポートは以下の分野をカバーしています：
- 呼吸器治療薬市場のサイジング
- 呼吸器治療薬市場の予測
- 呼吸器治療薬市場の産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、アボットラボラトリーズ、AbbVie Inc、AstraZeneca Plc、Aurobindo Pharma Ltd.、Boehringer Ingelheim International GmbH、Celon Pharma SA、Cipla Ltd.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Laboratory Corp.Inc.、ノバルティスAG、住友製薬株式会社、テバ・ファーマシューティカル・インダストリーズ・リミテッド（Teva Pharmaceutical Industries Ltd.Ltd.、Teva Pharmaceutical Industries Ltd.、Vertex Pharmaceuticals Inc.、Wellona Pharma、Glenmark Pharmaceuticals Ltd.などである。また、呼吸器医薬品市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/respiratory-drugs-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global respiratory drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global respiratory drugs market 2017 - 2021 ($ billion)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o 6.4 Retail pharmacies - Market size and forecast 2022-2027
o Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacies - Market size and forecast 2022-2027
o Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ billion)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Asthma - Market size and forecast 2022-2027
o Exhibit 52: Chart on Asthma - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Asthma - Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Asthma - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
o 7.4 COPD - Market size and forecast 2022-2027
o Exhibit 56: Chart on COPD - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on COPD - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on COPD - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on COPD - Year-over-year growth 2022-2027 (%)
o 7.5 Allergic rhinitis - Market size and forecast 2022-2027
o Exhibit 60: Chart on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
o 7.6 Cystic fibrosis - Market size and forecast 2022-2027
o Exhibit 64: Chart on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
o 7.7 Other respiratory diseases - Market size and forecast 2022-2027
o Exhibit 68: Chart on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Type
o Exhibit 72: Market opportunity by Type ($ billion)
o Exhibit 73: Data Table on Market opportunity by Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 Canada - Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 111: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 123: Abbott Laboratories - Overview
o Exhibit 124: Abbott Laboratories - Business segments
o Exhibit 125: Abbott Laboratories - Key news
o Exhibit 126: Abbott Laboratories - Key offerings
o Exhibit 127: Abbott Laboratories - Segment focus
o 12.4 AbbVie Inc.
o Exhibit 128: AbbVie Inc. - Overview
o Exhibit 129: AbbVie Inc. - Product / Service
o Exhibit 130: AbbVie Inc. - Key news
o Exhibit 131: AbbVie Inc. - Key offerings
o 12.5 Aerogen Pharma Ltd.
o Exhibit 132: Aerogen Pharma Ltd. - Overview
o Exhibit 133: Aerogen Pharma Ltd. - Product / Service
o Exhibit 134: Aerogen Pharma Ltd. - Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 135: AstraZeneca Plc - Overview
o Exhibit 136: AstraZeneca Plc - Product / Service
o Exhibit 137: AstraZeneca Plc - Key news
o Exhibit 138: AstraZeneca Plc - Key offerings
o 12.7 Boehringer Ingelheim International GmbH
o Exhibit 139: Boehringer Ingelheim International GmbH - Overview
o Exhibit 140: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 141: Boehringer Ingelheim International GmbH - Key news
o Exhibit 142: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 143: Boehringer Ingelheim International GmbH - Segment focus
o 12.8 Celon Pharma SA
o Exhibit 144: Celon Pharma SA - Overview
o Exhibit 145: Celon Pharma SA - Business segments
o Exhibit 146: Celon Pharma SA - Key offerings
o Exhibit 147: Celon Pharma SA - Segment focus
o 12.9 Cipla Ltd.
o Exhibit 148: Cipla Ltd. - Overview
o Exhibit 149: Cipla Ltd. - Business segments
o Exhibit 150: Cipla Ltd. - Key news
o Exhibit 151: Cipla Ltd. - Key offerings
o Exhibit 152: Cipla Ltd. - Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 153: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 154: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 155: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 156: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 157: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 GlaxoSmithKline Plc
o Exhibit 158: GlaxoSmithKline Plc - Overview
o Exhibit 159: GlaxoSmithKline Plc - Business segments
o Exhibit 160: GlaxoSmithKline Plc - Key news
o Exhibit 161: GlaxoSmithKline Plc - Key offerings
o Exhibit 162: GlaxoSmithKline Plc - Segment focus
o 12.12 Glenmark Pharmaceuticals Ltd.
o Exhibit 163: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 164: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 165: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.13 Lupin Ltd.
o Exhibit 166: Lupin Ltd. - Overview
o Exhibit 167: Lupin Ltd. - Product / Service
o Exhibit 168: Lupin Ltd. - Key news
o Exhibit 169: Lupin Ltd. - Key offerings
o 12.14 Novartis AG
o Exhibit 170: Novartis AG - Overview
o Exhibit 171: Novartis AG - Business segments
o Exhibit 172: Novartis AG - Key offerings
o Exhibit 173: Novartis AG - Segment focus
o 12.15 Sumitomo Pharma Co. Ltd.
o Exhibit 174: Sumitomo Pharma Co. Ltd. - Overview
o Exhibit 175: Sumitomo Pharma Co. Ltd. - Business segments
o Exhibit 176: Sumitomo Pharma Co. Ltd. - Key offerings
o Exhibit 177: Sumitomo Pharma Co. Ltd. - Segment focus
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 178: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 179: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 180: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 181: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 182: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Vertex Pharmaceuticals Inc.
o Exhibit 183: Vertex Pharmaceuticals Inc. - Overview
o Exhibit 184: Vertex Pharmaceuticals Inc. - Product / Service
o Exhibit 185: Vertex Pharmaceuticals Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 186: Inclusions checklist
o Exhibit 187: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 188: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 189: Research methodology
o Exhibit 190: Validation techniques employed for market sizing
o Exhibit 191: Information sources
o 13.5 List of abbreviations
o Exhibit 192: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global respiratory drugs market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ billion)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits48: Chart on Type - Market share 2022-2027 (%)
Exhibits49: Data Table on Type - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Asthma - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Asthma - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Asthma - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on COPD - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on COPD - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on COPD - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on COPD - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by Type ($ billion)
Exhibits73: Data Table on Market opportunity by Type ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2022 and 2027
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories - Overview
Exhibits124: Abbott Laboratories - Business segments
Exhibits125: Abbott Laboratories - Key news
Exhibits126: Abbott Laboratories - Key offerings
Exhibits127: Abbott Laboratories - Segment focus
Exhibits128: AbbVie Inc. - Overview
Exhibits129: AbbVie Inc. - Product / Service
Exhibits130: AbbVie Inc. - Key news
Exhibits131: AbbVie Inc. - Key offerings
Exhibits132: Aerogen Pharma Ltd. - Overview
Exhibits133: Aerogen Pharma Ltd. - Product / Service
Exhibits134: Aerogen Pharma Ltd. - Key offerings
Exhibits135: AstraZeneca Plc - Overview
Exhibits136: AstraZeneca Plc - Product / Service
Exhibits137: AstraZeneca Plc - Key news
Exhibits138: AstraZeneca Plc - Key offerings
Exhibits139: Boehringer Ingelheim International GmbH - Overview
Exhibits140: Boehringer Ingelheim International GmbH - Business segments
Exhibits141: Boehringer Ingelheim International GmbH - Key news
Exhibits142: Boehringer Ingelheim International GmbH - Key offerings
Exhibits143: Boehringer Ingelheim International GmbH - Segment focus
Exhibits144: Celon Pharma SA - Overview
Exhibits145: Celon Pharma SA - Business segments
Exhibits146: Celon Pharma SA - Key offerings
Exhibits147: Celon Pharma SA - Segment focus
Exhibits148: Cipla Ltd. - Overview
Exhibits149: Cipla Ltd. - Business segments
Exhibits150: Cipla Ltd. - Key news
Exhibits151: Cipla Ltd. - Key offerings
Exhibits152: Cipla Ltd. - Segment focus
Exhibits153: F. Hoffmann La Roche Ltd. - Overview
Exhibits154: F. Hoffmann La Roche Ltd. - Business segments
Exhibits155: F. Hoffmann La Roche Ltd. - Key news
Exhibits156: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits157: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits158: GlaxoSmithKline Plc - Overview
Exhibits159: GlaxoSmithKline Plc - Business segments
Exhibits160: GlaxoSmithKline Plc - Key news
Exhibits161: GlaxoSmithKline Plc - Key offerings
Exhibits162: GlaxoSmithKline Plc - Segment focus
Exhibits163: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits164: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits165: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits166: Lupin Ltd. - Overview
Exhibits167: Lupin Ltd. - Product / Service
Exhibits168: Lupin Ltd. - Key news
Exhibits169: Lupin Ltd. - Key offerings
Exhibits170: Novartis AG - Overview
Exhibits171: Novartis AG - Business segments
Exhibits172: Novartis AG - Key offerings
Exhibits173: Novartis AG - Segment focus
Exhibits174: Sumitomo Pharma Co. Ltd. - Overview
Exhibits175: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits176: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits177: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits178: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits179: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits180: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits181: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits182: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits183: Vertex Pharmaceuticals Inc. - Overview
Exhibits184: Vertex Pharmaceuticals Inc. - Product / Service
Exhibits185: Vertex Pharmaceuticals Inc. - Key offerings
Exhibits186: Inclusions checklist
Exhibits187: Exclusions checklist
Exhibits188: Currency conversion rates for US$
Exhibits189: Research methodology
Exhibits190: Validation techniques employed for market sizing
Exhibits191: Information sources
Exhibits192: List of abbreviations